Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy

被引：0
|
作者：
Min Yang
Hiroyuki Awano
Satoru Tanaka
Walter Toro
Su Zhang
Omar Dabbous
Ataru Igarashi
机构：
[1] Analysis Group,Department of Pediatrics
[2] Inc.,Unit of Public Health and Preventive Medicine
[3] Kobe University Graduate School of Medicine,Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences
[4] Novartis Pharma K.K.,undefined
[5] Novartis Gene Therapies,undefined
[6] Inc.,undefined
[7] Yokohama City University,undefined
[8] The University of Tokyo,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Disease-modifying therapies; Economic burden; Gene therapy; Health-related quality of life; Humanistic burden; Natural history; Nusinersen; Onasemnogene abeparvovec; Spinal muscular atrophy; Systematic literature review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1915 / 1958
页数：43
相关论文
共 50 条
  • [1] Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy
    Yang, Min
    Awano, Hiroyuki
    Tanaka, Satoru
    Toro, Walter
    Zhang, Su
    Dabbous, Omar
    Igarashi, Ataru
    ADVANCES IN THERAPY, 2022, 39 (05) : 1915 - 1958
  • [2] Systematic literature review of the economic burden and economic evaluations in spinal muscular atrophy
    Dangouloff, T.
    Servais, L.
    Hiligsmann, M.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S101 - S102
  • [3] Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments
    Dangouloff, Tamara
    Botty, Camille
    Beaudart, Charlotte
    Servais, Laurent
    Hiligsmann, Mickael
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [4] Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments
    Tamara Dangouloff
    Camille Botty
    Charlotte Beaudart
    Laurent Servais
    Mickaël Hiligsmann
    Orphanet Journal of Rare Diseases, 16
  • [5] Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
    Noman Paracha
    Pollyanna Hudson
    Stephen Mitchell
    C. Simone Sutherland
    PharmacoEconomics, 2022, 40 : 69 - 89
  • [6] Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
    Noman Paracha
    Pollyanna Hudson
    Stephen Mitchell
    C. Simone Sutherland
    PharmacoEconomics, 2022, 40 : 119 - 119
  • [7] Delay in Diagnosis of Spinal Muscular Atrophy: A Systematic Literature Review
    Lin, Chia-Wei
    Kalb, Stephanie J.
    Yeh, Wei-Shi
    PEDIATRIC NEUROLOGY, 2015, 53 (04) : 293 - 300
  • [8] Systematic Literature Review of the Natural History of Spinal Muscular Atrophy
    Ribero, Valerie Aponte
    Marti, Yasmina
    Batson, Sarah
    Mitchell, Stephen
    Gorni, Ksenija
    Gusset, Nicole
    Oskoui, Maryam
    Servais, Laurent
    Sutherland, C. Simone
    NEUROLOGY, 2023, 101 (21) : E2103 - E2113
  • [9] Current evidence for treatment with nusinersen for spinal muscular atrophy: a systematic review
    Antoon Meylemans
    Jan De Bleecker
    Acta Neurologica Belgica, 2019, 119 : 523 - 533
  • [10] Current evidence for treatment with nusinersen for spinal muscular atrophy: a systematic review
    Meylemans, A.
    De Bleecker, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 225 - 225
12345